Skip to main content
. 2021 Jul 7;16(7):e0252924. doi: 10.1371/journal.pone.0252924

Table 1. An overview on approved compounds for the indication “glioblastoma”.

Name Target structure Year of Approval Year of designation
5-aminolevulinic acid intraoperative optical imaging agent 2017 2013
Bevacizumab Inhibition of angiogenesis (antibody against VEGF) 2009 2006
Polifeprosan 20 with carmustine Implant to deliver the approved drug carmustine 2003 1989
Lomustine Alkylating compound 1976 unknown
Temozolomide Alkylating compound 2006 1998